Bioneercorporation바이오니아
064550 · KOSDAQ · ₩064550 · 바이오니아
₩7,070 ₩0 (0.00%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 76.8% | 77.9% | 74.8% | 77.1% | 76.3% | 77.9% |
| Operating margin | 1.8% | 4.6% | −4.6% | 0.3% | 5.3% | 21.0% |
| Net margin | −1.9% | −0.9% | −7.0% | −4.0% | 5.5% | 12.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +4.8% | +12.3% | +11.7% | +20.5% | −2.4% | — |
| Operating income growth | −59.0% | +213.5% | −1,794.5% | −93.1% | −75.5% | — |
| Net income growth | −137.2% | +86.3% | −94.4% | −187.7% | −55.5% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −3.2% | −1.3% | −9.4% | −4.6% | 5.5% | 13.4% |
| Return on assets | 0.1% | 0.5% | −5.9% | −2.3% | 5.4% | 11.1% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 69.7% | 63.0% | 46.4% | 34.3% | 22.7% | 26.4% |
| Net debt to equity | −18.6% | −21.2% | −16.1% | −9.8% | −7.1% | −14.3% |
| Current ratio | 200.1% | 225.3% | 226.4% | 274.8% | 370.0% | 268.6% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Bioneercorporation / 바이오니아 / 064550 / KRX:064550
Source: KRX statistical information